Log in
Enquire now

List of Valerion Therapeutics patents

List of Valerion Therapeutics patents
List of Freedom Scientific patents
List of LG Household & Health Care patents
List of Silenseed patents
List of funding rounds for InVision
Web scraping venture capital investors
Patents where
Current Assignee
Name
is
Valerion TherapeuticsValerion Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10238753 Antisense conjugates for decreasing expression of DMPK

Patent 10238753 was granted and assigned to Valerion Therapeutics on March, 2019 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10238753
March 26, 2019
‌
US Patent 9610362 Antisense conjugates for decreasing expression of DMPK

Patent 9610362 was granted and assigned to Valerion Therapeutics on April, 2017 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9610362
April 4, 2017
‌
US Patent 10017581 Methods and compositions for treatment of Pompe disease

Patent 10017581 was granted and assigned to Valerion Therapeutics on July, 2018 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10017581
July 10, 2018
‌
US Patent 9114178 Methods and compositions for treatment of myotonic dystrophy

Patent 9114178 was granted and assigned to Valerion Therapeutics on August, 2015 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9114178
August 25, 2015
‌
US Patent 10703824 Internalizing moieties

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10703824
July 7, 2020
‌
US Patent 9447394 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides

Patent 9447394 was granted and assigned to Valerion Therapeutics on September, 2016 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9447394
September 20, 2016
‌
US Patent 10781434 Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10781434
September 22, 2020
‌
US Patent 10202591 Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders

Patent 10202591 was granted and assigned to Valerion Therapeutics on February, 2019 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10202591
February 12, 2019
‌
US Patent 10501554 Internalizing moieties for treatment of cancer

Patent 10501554 was granted and assigned to Valerion Therapeutics on December, 2019 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10501554
December 10, 2019
‌
US Patent 10221250 Internalizing moieties

Patent 10221250 was granted and assigned to Valerion Therapeutics on March, 2019 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10221250
March 5, 2019
‌
US Patent 8834866 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides

Patent 8834866 was granted and assigned to Valerion Therapeutics on September, 2014 by the United States Patent and Trademark Office.

Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8834866
September 16, 2014
‌
US Patent 10781433 Methods and compositions for treatment of Lafora disease

Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10781433
September 22, 2020
‌
US Patent 8609615 Methods and compositions for treatment of myotonic dystrophy

Valerion Therapeutics
Valerion Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8609615
December 17, 2013
13 results
0 selected
13 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us